Judges Scientific Regulatory News (JDG)

Judges Scientific plc (the "Company")

7 June 2013

Director/PDMR Shareholding

Judges Scientific plc has been advised that purchases of Ordinary Shares of 5p each in the Company ('Ordinary Shares') were made today by the Trustees of the Share Incentive Plan on behalf of two Directors of the Company, as follows:

A total of 10 Ordinary Shares were purchased on behalf of David Cicurel, the Chief Executive Officer of the Company, to which the Company added a further 10 Ordinary Shares under the "matching" provisions of the Plan rules. His resulting interest in the Company is 916,322 Ordinary Shares representing 17.23 per cent of the issued Ordinary share capital.

A total of 10 Ordinary Shares were purchased on behalf of Ralph Cohen, the Finance Director of the Company, to which the Company added a further 10 Ordinary Shares under the "matching" provisions of the Plan rules. His resulting interest in the Company is 50,841 Ordinary Shares representing 0.96 per cent of the issued Ordinary share capital. In addition, he holds options over 43,100 Ordinary Shares under the Company's Share Option Plans.

The purchases by the Trustees were made at a price of 1310.0p per Ordinary Share. Purchases of a further 707 Ordinary Shares were made on the same date and at the same price on behalf of 52 other members of staff under the Plan.

For further information please contact:

Judges Scientific Plc

David Cicurel, CEO

Tel: 01342 323 600

Shore Capital (Nominated Adviser & Broker)

Pascal Keane

Edward Mansfield

Tel: 020 7408 4090

Cardew Group (Financial Public Relations)

Nadja Vetter

Tel: 020 7930 0777 or 07941 340436

Website:

Judges Scientific: www.judges.uk.com